Model
Edge
Seres Therapeutics
0001814656
Filing Type
4
Filing Date
8/5/2024
Updated
8/6/24, 2:15 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership